Skip to main content
Premium Trial:

Request an Annual Quote

Scope Fluidics: Carl Wittwer

Carl Wittwer has been appointed to the advisory committee of Scope Fluidics. Wittwer, who is credited as one of the creators of PCR, has specialized in developing ultra-rapid PCR chemistries and was a co-founder of BioFire Diagnostics. Wittwer will advise the Warsaw, Poland-based firm in the futher development of its 15-minute sample-to-answer multiplex PCR One system for which it is currently developing SARS-CoV-2 assays. 

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.